Fig. 4From: Development and validation of a novel stem cell subtype for bladder cancer based on stem genomic profilingSurvival analysis of patients with different BLCA stem cell subtypes. Comparison of survival prognosis between BLCA subtypes in overall survival (OS) of a TCGA, f GSE31684, g GSE32548, and h GSE32894 and relapse-free survival (RFS) in b TCGA together with progression-free survival (PFS) in c TCGA, d E-MTAB-4321, and e GSE13507. BLCA, bladder cancer; TCGA, The Cancer Genome AtlasBack to article page